noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Lake Street Capital Markets LLC

02/11/2026 | Press release | Archived content

Daxor Corporation (DXR) - Initiation of Coverage

Lake Street Capital Markets Analyst, Frank Takkinen, initiated coverage of Daxor Corporation with a BUY rating and price target of $23 (DXR-$23). Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.

‍

Want to stay up-to-date with the latest at Lake Street? Subscribe to our mailing list!

NameEmail Address

Thanks for joining our mailing list.

Oops! Something went wrong while submitting the form.

Attachment

Lake Street Capital Markets LLC published this content on February 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 16, 2026 at 10:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format